Endpoints News 生物医药· Max Gelman·· 18 天前AI 评分30
FDA 对 Bright Minds 试验抗癫痫药物部分暂停临床试验
FDA puts Bright Minds drug on partial hold, stock tanks
AI 导读
FDA 对 Bright Minds 生物科学公司的一款试验抗癫痫药物实施部分临床暂停,具体原因未详述。
正文
The FDA placed an experimental seizure drug from Bright Minds Biosciences on a partial clinical hold, the company announced Monday.
Regulators issued the hold for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news